HHS Shields Three Ebola Vaccine Makers From Legal Liability

 
• By Brenda Sandburg

GlaxoSmithKline, NewLink Genetics and Johnson & Johnson gain protection for their candidate Ebola vaccines; NewLink teams up with Merck, and GSK prepares for Phase II/III studies in West Africa.

More from Archive

More from Pink Sheet